title: A case of severe cholestatic jaundice associated with Graves' disease.
authors.forename: Dilek
authors.initials: D
authors.lastname: Soysal
authors.forename: Erhan
authors.initials: E
authors.lastname: Tatar
authors.forename: Serife
authors.initials: S
authors.lastname: Solmaz
authors.forename: Ozlem
authors.initials: O
authors.lastname: Kabayeğit
authors.forename: Mine
authors.initials: M
authors.lastname: Tunakan
authors.forename: Belkis
authors.initials: B
authors.lastname: Unsal
authors.forename: Cetin
authors.initials: C
authors.lastname: Cevik
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D013956:Antithyroid Agents / Q000627:therapeutic use; D049448:Cholangiopancreatography, Magnetic Resonance; D002779:Cholestasis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D006111:Graves Disease / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy / Q000601:surgery; D006801:Humans; D008099:Liver / Q000000981:diagnostic imaging / Q000473:pathology; D008111:Liver Function Tests; D008297:Male; D008713:Methimazole / Q000627:therapeutic use; D008875:Middle Aged; D011433:Propranolol / Q000627:therapeutic use; D011877:Radionuclide Imaging; D013960:Thyroid Function Tests; D013961:Thyroid Gland / Q000000981:diagnostic imaging / Q000473:pathology / Q000601:surgery; D013965:Thyroidectomy; D013974:Thyroxine / Q000627:therapeutic use; D014463:Ultrasonography
chemical_list: D000319:Adrenergic beta-Antagonists; D013956:Antithyroid Agents; D008713:Methimazole; D011433:Propranolol; D013974:Thyroxine